Munich - Delayed Quote EUR

Cellectis SA (ZVA.MU)

Compare

1.5060

-0.0600

(-3.83%)

As of 8:11:06 AM GMT+1. Market Open.

Currency in USD All numbers in thousands

Download

Breakdown

TTM

12/31/2023

12/31/2022

12/31/2021

12/31/2020

Total Revenue

29,072.0000

755.0000

19,171.0000

30,346.0000

51,057.0000

Cost of Revenue

737.0000

1,772.0000

1,844.0000

1,951.0000

Gross Profit

18.0000

17,399.0000

28,502.0000

49,106.0000

Operating Expense

106,788.0000

97,320.0000

107,065.0000

131,984.0000

91,418.0000

Operating Income

-78,453.0000

-97,302.0000

-89,666.0000

-103,482.0000

-42,312.0000

Net Non Operating Interest Income Expense

1,885.0000

-2,812.0000

-14,994.0000

-3,011.0000

-680.0000

Other Income Expense

-8,240.0000

-16,352.0000

6,060.0000

9,741.0000

-10,590.0000

Pretax Income

-84,808.0000

-116,466.0000

-98,600.0000

-96,752.0000

-53,582.0000

Tax Provision

-508.0000

371.0000

87.0000

Net Income Common Stockholders

-84,478.0000

-101,059.0000

-106,139.0000

-114,197.0000

-81,074.0000

Diluted NI Available to Com Stockholders

-84,478.0000

-101,059.0000

-106,139.0000

-114,197.0000

-81,074.0000

Basic EPS

-1.17

-1.77

-2.33

-1.91

Diluted EPS

-1.17

-1.77

-2.33

-1.91

Basic Average Shares

81,855.5620

57,012.8150

45,553.2190

42,447.1200

42,503.4470

Diluted Average Shares

81,855.5620

57,012.8150

45,553.2190

42,447.1200

42,590.4070

Total Operating Income as Reported

-78,453.0000

-97,302.0000

-89,666.0000

-103,481.0000

-42,311.0000

Total Expenses

107,525.0000

98,057.0000

108,837.0000

133,828.0000

93,369.0000

Net Income from Continuing & Discontinued Operation

-84,478.0000

-101,059.0000

-106,139.0000

-114,197.0000

-81,074.0000

Normalized Income

-76,287.3576

-97,187.0000

-95,339.0000

-95,580.0000

-26,582.0000

Interest Income

9,158.0000

3,614.0000

1,120.0000

719.0000

1,392.0000

Interest Expense

7,091.0000

5,307.0000

3,787.0000

4,171.0000

2,407.0000

Net Interest Income

1,885.0000

-2,812.0000

-14,994.0000

-3,011.0000

-680.0000

EBIT

-77,717.0000

-111,159.0000

-94,813.0000

-92,581.0000

-51,175.0000

EBITDA

-58,518.0000

-92,636.0000

-76,378.0000

-78,425.0000

-43,341.0000

Reconciled Cost of Revenue

737.0000

1,772.0000

1,844.0000

1,951.0000

Reconciled Depreciation

19,199.0000

18,523.0000

18,435.0000

14,156.0000

7,834.0000

Net Income from Continuing Operation Net Minority Interest

-84,478.0000

-109,451.0000

-90,794.0000

-85,839.0000

-37,172.0000

Total Unusual Items Excluding Goodwill

-8,240.0000

-16,352.0000

6,060.0000

9,741.0000

-10,590.0000

Total Unusual Items

-8,240.0000

-16,352.0000

6,060.0000

9,741.0000

-10,590.0000

Normalized EBITDA

-50,278.0000

-76,284.0000

-82,438.0000

-88,166.0000

-32,751.0000

Tax Rate for Calcs

0.0000

0.0003

Tax Effect of Unusual Items

-49.3576

-4,088.0000

1,515.0000

12/31/2020 - 8/27/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

GBY.MU Sangamo Therapeutics Inc

2.0855

-23.50%

R3X1.F Opus Genetics, Inc.

1.0200

+6.81%

BLE.MU bluebird bio, Inc.

0.0000

0.00%

SYBX Synlogic, Inc.

1.3741

-3.23%

ARCT Arcturus Therapeutics Holdings Inc.

15.51

+4.51%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Cellectis SA (ZVA.MU)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers